
Preclinical CRO Market Share, Size, Trends, Industry Analysis Report, By Service Type (Toxicology Testing, Bioanalysis & DMPK studies, Chemistry, Compound Management, Others); By Mode; By End-User; By Region; Segment Forecast, 2024 - 2032
Description
Preclinical CRO Market Share, Size, Trends, Industry Analysis Report, By Service Type (Toxicology Testing, Bioanalysis & DMPK studies, Chemistry, Compound Management, Others); By Mode; By End-User; By Region; Segment Forecast, 2024 - 2032
The global preclinical CRO market size is expected to reach USD 11.90 billion by 2032, according to a new study by Polaris Market Research. The report “Preclinical CRO Market Share, Size, Trends, Industry Analysis Report, By Service Type (Toxicology Testing, Bioanalysis & DMPK studies, Chemistry, Compound Management, Others); By Mode; By End-User; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
CROs offering a comprehensive range of preclinical services, including toxicology, pharmacokinetics, and bioanalytical services, are strategically positioned to meet the diverse and evolving needs of pharmaceutical and biotech companies. Regulatory agencies' are increasing focus on stringent safety and efficacy assessments in drug development has elevated the demand for high-quality preclinical studies, favoring CROs with a strong track record of regulatory compliance.
Also, the globalization of pharmaceutical research and development activities has opened opportunities for preclinical CROs to expand their services internationally, catering to the diverse needs of clients in different geographic regions.
The landscape of the preclinical CRO market is characterized by dynamism influenced by several pivotal factors. Primarily, there is a progressive trend in the pharmaceutical and biotechnology sectors towards outsourcing preclinical research and drug development functions to specialized CROs. This shift is primarily fueled by the pursuit of cost-efficiency and time savings, as companies leverage the specialized expertise and infrastructure of CROs to expedite the drug development process.
With the growing complexity and cost of drug research and development procedures, the outsourcing trend becomes increasingly appealing. Additionally, the emergence of biologics and biosimilars has heightened the demand for preclinical CRO services, given the specialized testing and expertise required for these innovative drugs.
Moreover, the underdeveloped infrastructure in emerging economies, restricting research and development (R&D) endeavors, is expected to hinder the market's expansion. Nevertheless, considerable governmental investments in R&D and the concerted efforts of key industry players to augment preclinical trials open new avenues for firms in the worldwide preclinical CRO market. Furthermore, the inclination towards strategic collaborations between regional entities and public stakeholders is foreseen to offer revenue reinforcement, contributing to the market's overall growth.
Preclinical MRO Market Report Highlights
In 2023, the bioanalysis & DMPK studies segment is expected to witness highest growth during forecast period owing to increasing demand for pharmacokinetic services
Patient-Derived Organoids (PDOs) segment is expected to dominate the preclinical CRO market during forecast period. This is attributed to growing emphasis on precision medicine by pharmaceutical and biotech companies
Government and academic institutes segment is expected to witness highest growth during forecast period
In 2023, North America accounted for the largest revenue share due to presence of major players, technological advancements, and increasing R&D innovations.
The market is highly competitive owing to the existence of market players with a global presence, including Charles River Laboratories, Covance (LabCorp), Envigo, Eurofins Scientific, Pharmaceutical Product Development, LLC (PPD), QuintilesIMS (IQVIA), Syngene International, among others.
Polaris Market Research has segmented the preclinical CRO market report based on service type, mode, end-users, and region:
Preclinical MRO, Service Type Outlook (Revenue - USD Billion, 2019 - 2032)
Toxicology Testing
Bioanalysis & DMPK studies
Chemistry
Compound Management
Others
Preclinical MRO, Mode Outlook (Revenue - USD Billion, 2019 - 2032)
Patient Derived Organoid (PDO) Model
Patient-Derived Xenograft (PDX) Model
Preclinical MRO, End-Users Outlook (Revenue - USD Billion, 2019 - 2032)
Government and Academic Institutes
Biopharmaceutical Companies
Medical Device Companies
Preclinical MRO, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Netherlands
Spain
Russia
Asia Pacific
Japan
China
India
Malaysia
Indonesia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Table of Contents
118 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Preclinical CRO Market Insights
- 4.1. Preclinical CRO Market – End-User Snapshot
- 4.2. Preclinical CRO Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing outsourcing trend is projected to spur the product demand.
- 4.2.1.2. Growing investment in R&D is expected to drive preclinical CRO market growth.
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Increasing competition among CROs is likely to impede the market preclinical CRO growth opportunities.
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Preclinical CRO Market End-User Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Preclinical CRO Market, by Service Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 5.3. Toxicology Testing
- 5.3.1. Global Preclinical CRO Market, by Toxicology Testing, by Region, 2019-2032 (USD Billion)
- 5.4. Bioanalysis & DMPK studies
- 5.4.1. Global Preclinical CRO Market, by Bioanalysis & DMPK studies, by Region, 2019-2032 (USD Billion)
- 5.5. Chemistry
- 5.5.1. Global Preclinical CRO Market, by Chemistry, by Region, 2019-2032 (USD Billion)
- 5.6. Compound Management
- 5.6.1. Global Preclinical CRO Market, by Compound Management, by Region, 2019-2032 (USD Billion)
- 5.7. Others
- 5.7.1. Global Preclinical CRO Market, by Others, by Region, 2019-2032 (USD Billion)
- 6. Global Preclinical CRO Market, by Mode
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 6.3. Patient Derived Organoid (PDO) Model
- 6.3.1. Global Preclinical CRO Market, by Patient Derived Organoid (PDO) Model, by Region, 2019-2032 (USD Billion)
- 6.4. Patient-Derived Xenograft (PDX) Model
- 6.4.1. Global Preclinical CRO Market, by Patient-Derived Xenograft (PDX) Model, by Region, 2019-2032 (USD Billion)
- 7. Global Preclinical CRO Market, by End-User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 7.3. Government and Academic Institutes
- 7.3.1. Global Preclinical CRO Market, by Government and Academic Institutes, By Region, 2019-2032 (USD Billion)
- 7.4. Biopharmaceutical Companies
- 7.4.1. Global Preclinical CRO Market, by Biopharmaceutical Companies, By Region, 2019-2032 (USD Billion)
- 7.5. Medical Device Companies
- 7.5.1. Global Preclinical CRO Market, by Medical Device Companies, By Region, 2019-2032 (USD Billion)
- 8. Global Preclinical CRO Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Preclinical CRO Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Preclinical CRO Market – North America
- 8.3.1. North America: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.3.2. North America: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.3.3. North America: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.3.4. Preclinical CRO Market – U.S.
- 8.3.4.1. U.S.: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.3.5. Preclinical CRO Market – Canada
- 8.3.5.1. Canada: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.4. Preclinical CRO Market – Europe
- 8.4.1. Europe: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.4.3. Europe: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.4.4. Preclinical CRO Market – UK
- 8.4.4.1. UK: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.4.5. Preclinical CRO Market – France
- 8.4.5.1. France: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.4.5.3. France: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.4.6. Preclinical CRO Market – Germany
- 8.4.6.1. Germany: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.4.7. Preclinical CRO Market – Italy
- 8.4.7.1. Italy: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.4.8. Preclinical CRO Market – Spain
- 8.4.8.1. Spain: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.4.9. Preclinical CRO Market – Netherlands
- 8.4.9.1. Netherlands: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.4.10. Preclinical CRO Market – Russia
- 8.4.10.1. Russia: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.5. Preclinical CRO Market – Asia Pacific
- 8.5.1. Asia Pacific: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.5.4. Preclinical CRO Market – China
- 8.5.4.1. China: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.5.4.3. China: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.5.5. Preclinical CRO Market – India
- 8.5.5.1. India: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.5.5.3. India: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.5.6. Preclinical CRO Market – Malaysia
- 8.5.6.1. Malaysia: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.5.7. Preclinical CRO Market – Japan
- 8.5.7.1. Japan: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.5.8. Preclinical CRO Market – Indonesia
- 8.5.8.1. Indonesia: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.5.9. Preclinical CRO Market – South Korea
- 8.5.9.1. South Korea: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.6. Preclinical CRO Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.6.4. Preclinical CRO Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.6.5. Preclinical CRO Market – UAE
- 8.6.5.1. UAE: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.6.6. Preclinical CRO Market – Israel
- 8.6.6.1. Israel: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.6.7. Preclinical CRO Market – South Africa
- 8.6.7.1. South Africa: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.7. Preclinical CRO Market – Latin America
- 8.7.1. Latin America: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.7.4. Preclinical CRO Market – Mexico
- 8.7.4.1. Mexico: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.7.5. Preclinical CRO Market – Brazil
- 8.7.5.1. Brazil: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 8.7.6. Preclinical CRO Market – Argentina
- 8.7.6.1. Argentina: Preclinical CRO Market, by Service Type, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Preclinical CRO Market, by End-User, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Preclinical CRO Market, by Mode, 2019-2032 (USD Billion)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. Charles River Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Covance (LabCorp)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Envigo
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Eurofins Scientific
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. ICON plc
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. InVentiv Health
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Medpace
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. MPI Research (Envigo)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. PAREXEL International Corporation
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Pharmaceutical Product Development, LLC (PPD)
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. QuintilesIMS (IQVIA)
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Syngene International
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Toxikon Corporation
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. WuXi AppTec
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Laboratory Corporation of America Holdings (LabCorp)
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.